EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
-0.14%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$315M
AUM Growth
+$315M
(+8.2%)
Cap. Flow
+$25.7M
Cap. Flow
% of AUM
8.16%
Top 10 Holdings %
Top 10 Hldgs %
61.35%
Holding
29
New
–
Increased
13
Reduced
6
Closed
2
Top Buys
| 1 |
Guardant Health
GH
|
$8.43M |
| 2 |
Humana
HUM
|
$8.09M |
| 3 |
Outset Medical
OM
|
$7.26M |
| 4 |
Adaptive Biotechnologies
ADPT
|
$6.24M |
| 5 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$4.95M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$7.36M |
| 2 |
Privia Health
PRVA
|
$4.26M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$3.41M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$2.88M |
| 5 |
Seer Inc
SEER
|
$2.74M |
Sector Composition
| 1 | Healthcare | 97.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AstraZeneca
AZN
$248B
| $27M | 8.56% |
449,565
+49,776
| +12% | +$2.99M |
|
|
2
Humana
HUM
$36.5B
| $26.7M | 8.46% |
68,521
+20,800
| +44% | +$8.09M |
|
3
IQVIA
IQV
$32.4B
| $19.4M | 6.17% |
81,177
-4,100
| -5% | -$982K |
|
4
Natera
NTRA
$23.1B
| $18.3M | 5.81% |
164,494
+1,300
| +0.8% | +$145K |
|
|
BPMC
5
DELISTED
Blueprint Medicines
BPMC
| $18.1M | 5.74% |
176,175
+35,412
| +25% | +$3.64M |
|
6
United Therapeutics
UTHR
$13.8B
| $18.1M | 5.74% |
98,038
| – | – |
|
|
7
Alnylam Pharmaceuticals
ALNY
$58.5B
| $17M | 5.4% |
90,102
-18,077
| -17% | -$3.41M |
|
|
8
Outset Medical
OM
$247M
| $16.5M | 5.22% |
332,800
+146,800
| +79% | +$7.26M |
|
9
argenx
ARGX
$43.6B
| $16.2M | 5.14% |
53,632
+400
| +0.8% | +$121K |
|
10
DexCom
DXCM
$29.5B
| $16.1M | 5.12% |
29,500
-4,700
| -14% | -$2.57M |
|
11
Inspire Medical Systems
INSP
$2.77B
| $16M | 5.07% |
68,653
+12,600
| +22% | +$2.93M |
|
|
12
Adaptive Biotechnologies
ADPT
$2.01B
| $15M | 4.76% |
441,466
+183,639
| +71% | +$6.24M |
|
|
AXNX
13
DELISTED
Axonics, Inc. Common Stock
AXNX
| $12.4M | 3.93% |
190,365
-44,200
| -19% | -$2.88M |
|
|
14
Guardant Health
GH
$8.41B
| $12M | 3.79% |
95,660
+67,400
| +238% | +$8.43M |
|
15
Agios Pharmaceuticals
AGIO
$2.19B
| $10.9M | 3.45% |
235,513
| – | – |
|
|
MRTX
16
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.2M | 2.92% |
52,000
-5,900
| -10% | -$1.04M |
|
|
CANO
17
DELISTED
Cano Health, Inc.
CANO
| $8.58M | 2.72% |
676,412
+180,312
| +36% | +$2.29M |
|
18
American Well
AMWL
$111M
| $8.21M | 2.6% |
901,300
+173,700
| +24% | +$1.58M |
|
|
DRNA
19
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $8.2M | 2.6% |
406,525
+245,400
| +152% | +$4.95M |
|
|
CMAX
20
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $5.96M | 1.89% |
616,770
+238,995
| +63% | +$2.31M |
|
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $5.36M | 1.7% |
29,544
-40,600
| -58% | -$7.36M |
|
22
Kymera Therapeutics
KYMR
$2.95B
| $2.17M | 0.69% |
37,000
| – | – |
|
23
C4 Therapeutics
CCCC
$185M
| $2.11M | 0.67% |
47,200
| – | – |
|
24
Arvinas
ARVN
$568M
| $1.89M | 0.6% |
23,000
| – | – |
|
25
4D Molecular Therapeutics
FDMT
$288M
| $1.54M | 0.49% |
57,090
| – | – |
|